α1-adrenoceptor antagonist profile of doxazosin and its enantiomers in isolated rabbit blood vessels

Chinese Journal of Pharmacology and Toxicology

Volumn 17, Issue 5, 2003, Pages 354-359

  Niu, Chang Qun ^a,b   Zhao, Ding ^a   Jia, Xiang Man ^a   Ren, Lei Ming ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b NCPC   (China)

Author keywords

Aorta, thoracic; Carotid arteries; Doxazosin; Enantiomers; Rabbits; Receptors, adrenergic, a

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DEOXYCORTICOSTERONE; DESIPRAMINE; DOXAZOSIN; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL; CAROTID ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENANTIOMER; MALE; NONHUMAN; PROSTATE HYPERTROPHY; THORACIC AORTA;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0345098588     PISSN: 10003002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lepor H, Shapiro E. Characterization of alpha1 adrenergic receptors in human benign prostatic hyperplasia [J]. J Urol, 1984, 132(6):1226-1229.
2. 3H]rauwolscine[J]. J Urol, 1986, 135(5):1038-1042.
3. Gup DI, Shapiro E, Baumann M, Lepor H. Autonomic receptors in human prostate adenomas[J]. J Urol, 1990, 143 (1):179-185.
4. Lepor H, Gup DI, Baumann M, Shapiro E. Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia[J]. Urology, 1988, 32(6 Suppl):21-26.
5. Wilde MI, Fitton A, McTavish D. Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia [J]. Drugs, 1993, 45(3):410-429.
6. Caine M, Pfau A, Perlberg S. The use of alpha-adrenergic blockers in benign prostatic obstruction [J]. Br J Urol, 1976, 48(4):255-263.
7. Lefevre-Borg F, O'Connor SE, Schoemaker H, Hicks PE, Lechaire J, Gautier E, et al. Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract[J]. Br J Pharmacol, 1993, 109(4):1282-1289.
8. 1C subtype [J]. Mol Pharmacol, 1994, 45(4):703-708.
9. 1C-) adrenoceptor subtype[J]. Br J Pharmacol, 1995, 115(5):781-786.
10. 1A-adrenoceptor selective antagonists [J]. Br J Pharmacol, 1999, 127(1): 252-258.
11. Hatano A, Tang R, Walden PD, Lepor H. The α-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate[J]. Eur J Pharmacol, 1996, 313 (1-2):135-143.
12. Yang ZH, Ren LM, Wu ZJ, Fu SX, Li YS. Selective effects of alfuzosin and doxazosin with intraduodenal administration on urethral pressure of cats[J]. Acta Pharmacol Sin, 1999, 20(5):431-434.
13. Niu CQ, Ren LM. Chiral separation and preparation of three new antagonists of alpha 1-adrenoceptors by chiral mobile phase HPLC[J]. Acta Pharm Sin, 2002, 37 (6):450-453.
14. 2x-receptors in rabbit isolated ear artery [J]. Br J Pharmacol, 1990, 101(3):640-644.
15. Ren LM, Burnstock G. Prominent sympathetic purinergic vasoconstriction in the rabbit splenic artery: potentiation by 2,2′-pyridylisatogen tosylate[J]. Br J Pharmacol, 1997, 120(3):530-536.
16. 2x-receptors in the rabbit isolated ear artery [J]. Br J Pharmacol, 1990, 101 (3):645-649.
17. 1-adrenoceptors in vascular smooth muscle[J]. Br J Pharmacol, 1990, 99 (1):197-201.
18. Arunlakshana O, Schild HO. Some quantitative uses of drug antagonists[J]. Br J Pharmacol Chemother, 1959, 14(1): 48-58.
19. Taniguchi N, Ukai Y, Tanaka T, Yano J, Kimura K, Moriyama N, et al. Identification of alpha 1-adrenoceptor subtypes in the human prostatic urethra [J]. Naunyn Schmiedebergs Arch Pharmacol, 1997, 355(3):412-416.
20. Fulton B, Wagstaff AJ, Sorkin EM. Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia [J]. Drugs, 1995, 49(2):295-320.